News LCT diabetes treatment successful in pre-clinical trials Scientists from Living Cell Technologies (LCT) are reporting today at the International Transplantation Society Conference in Vienna that they had successfully implanted insulin-producing cells (islets) into diabetic mice and healthy monkeys. This proof of principle demonstration paves the way for the scientists to confidently continue their work in diabetic monkeys with a view to developing this technology for therapeutic use in humans. Related Document |